Increasing the density of nanomedicines improves their ultrasound-mediated delivery to tumours
Nanomedicines have provided fresh impetus in the fight against cancer due to their selectivity and power. However, these agents are limited when delivered intravenously due to their rapid clearance from the bloodstream and poor passage from the bloodstream into target tumours. Here we describe a nov...
| Main Authors: | , , , , , , , , |
|---|---|
| Format: | Journal article |
| Language: | English |
| Published: |
Elsevier
2015
|
| _version_ | 1797095159486218240 |
|---|---|
| author | Mo, S Carlisle, R Laga, R Myers, R Graham, S Cawood, R Ulbrich, K Seymour, L Coussios, C |
| author_facet | Mo, S Carlisle, R Laga, R Myers, R Graham, S Cawood, R Ulbrich, K Seymour, L Coussios, C |
| author_sort | Mo, S |
| collection | OXFORD |
| description | Nanomedicines have provided fresh impetus in the fight against cancer due to their selectivity and power. However, these agents are limited when delivered intravenously due to their rapid clearance from the bloodstream and poor passage from the bloodstream into target tumours. Here we describe a novel stealthing strategy which addresses both these limitations and thereby demonstrate that both the passive and mechanically-mediated tumour accumulation of the model nanomedicine adenovirus (Ad) can be substantially enhanced. In our strategy gold nanoparticles were thoroughly modified with 2kDa polyethyleneglycol (PEG) and then linked to Ad via a single reduction-cleavable 5kDa PEG. The resulting Ad-gold-PEG construct was compared to non-modified Ad or conventionally stealthed Ad-poly[N-(2-hydroxypropyl)methacrylamide] (Ad-PHPMA). Notably, although Ad-gold-PEG was of similar size and surface charge to Ad-PHPMA the increase in density, resulting from the inclusion of the gold nanoparticles, provided a substantial enhancement of ultrasound-mediated transport. In an in vitro tumour mimicking phantom, the level and distance of Ad-gold-PEG transport was shown to be substantially greater than achieved with Ad-PHPMA. In in vivo studies 0.1% of an unmodified Ad dose was shown to accumulate in tumours, whereas over 12% of the injected dose was recovered from the tumours of mice treated with Ad-gold-PEG and ultrasound. Ultimately, a significant increase in anti-tumour efficacy resulted from this strategy. This stealthing and density-increasing technology could ultimately enhance clinical utility of intravenously delivered nanoscale medicines including viruses, liposomes and antibodies. |
| first_indexed | 2024-03-07T04:23:53Z |
| format | Journal article |
| id | oxford-uuid:cbf613b9-e01d-4a14-844d-616e7fda9660 |
| institution | University of Oxford |
| language | English |
| last_indexed | 2024-03-07T04:23:53Z |
| publishDate | 2015 |
| publisher | Elsevier |
| record_format | dspace |
| spelling | oxford-uuid:cbf613b9-e01d-4a14-844d-616e7fda96602022-03-27T07:18:29ZIncreasing the density of nanomedicines improves their ultrasound-mediated delivery to tumoursJournal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:cbf613b9-e01d-4a14-844d-616e7fda9660EnglishSymplectic Elements at OxfordElsevier2015Mo, SCarlisle, RLaga, RMyers, RGraham, SCawood, RUlbrich, KSeymour, LCoussios, CNanomedicines have provided fresh impetus in the fight against cancer due to their selectivity and power. However, these agents are limited when delivered intravenously due to their rapid clearance from the bloodstream and poor passage from the bloodstream into target tumours. Here we describe a novel stealthing strategy which addresses both these limitations and thereby demonstrate that both the passive and mechanically-mediated tumour accumulation of the model nanomedicine adenovirus (Ad) can be substantially enhanced. In our strategy gold nanoparticles were thoroughly modified with 2kDa polyethyleneglycol (PEG) and then linked to Ad via a single reduction-cleavable 5kDa PEG. The resulting Ad-gold-PEG construct was compared to non-modified Ad or conventionally stealthed Ad-poly[N-(2-hydroxypropyl)methacrylamide] (Ad-PHPMA). Notably, although Ad-gold-PEG was of similar size and surface charge to Ad-PHPMA the increase in density, resulting from the inclusion of the gold nanoparticles, provided a substantial enhancement of ultrasound-mediated transport. In an in vitro tumour mimicking phantom, the level and distance of Ad-gold-PEG transport was shown to be substantially greater than achieved with Ad-PHPMA. In in vivo studies 0.1% of an unmodified Ad dose was shown to accumulate in tumours, whereas over 12% of the injected dose was recovered from the tumours of mice treated with Ad-gold-PEG and ultrasound. Ultimately, a significant increase in anti-tumour efficacy resulted from this strategy. This stealthing and density-increasing technology could ultimately enhance clinical utility of intravenously delivered nanoscale medicines including viruses, liposomes and antibodies. |
| spellingShingle | Mo, S Carlisle, R Laga, R Myers, R Graham, S Cawood, R Ulbrich, K Seymour, L Coussios, C Increasing the density of nanomedicines improves their ultrasound-mediated delivery to tumours |
| title | Increasing the density of nanomedicines improves their ultrasound-mediated delivery to tumours |
| title_full | Increasing the density of nanomedicines improves their ultrasound-mediated delivery to tumours |
| title_fullStr | Increasing the density of nanomedicines improves their ultrasound-mediated delivery to tumours |
| title_full_unstemmed | Increasing the density of nanomedicines improves their ultrasound-mediated delivery to tumours |
| title_short | Increasing the density of nanomedicines improves their ultrasound-mediated delivery to tumours |
| title_sort | increasing the density of nanomedicines improves their ultrasound mediated delivery to tumours |
| work_keys_str_mv | AT mos increasingthedensityofnanomedicinesimprovestheirultrasoundmediateddeliverytotumours AT carlisler increasingthedensityofnanomedicinesimprovestheirultrasoundmediateddeliverytotumours AT lagar increasingthedensityofnanomedicinesimprovestheirultrasoundmediateddeliverytotumours AT myersr increasingthedensityofnanomedicinesimprovestheirultrasoundmediateddeliverytotumours AT grahams increasingthedensityofnanomedicinesimprovestheirultrasoundmediateddeliverytotumours AT cawoodr increasingthedensityofnanomedicinesimprovestheirultrasoundmediateddeliverytotumours AT ulbrichk increasingthedensityofnanomedicinesimprovestheirultrasoundmediateddeliverytotumours AT seymourl increasingthedensityofnanomedicinesimprovestheirultrasoundmediateddeliverytotumours AT coussiosc increasingthedensityofnanomedicinesimprovestheirultrasoundmediateddeliverytotumours |